Halia Therapeutics, Inc. · 3 days ago
Associate Director / Director of Clinical Data Management
Halia Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. They are seeking an experienced Associate Director or Director of Clinical Data Management to lead the data strategy, execution, and quality oversight of clinical data across its expanding development pipeline.
BiotechnologyMedicalNeurosciencePharmaceutical
Responsibilities
Lead the clinical data management function across all clinical programs, ensuring compliance with GCP, regulatory requirements, and industry standards
Develop and implement CDM strategies, processes, and infrastructure to support therapeutic areas in inflammation and neurology
Oversee end‑to‑end data lifecycle including CRF design, database build, data cleaning, coding, reconciliation, and database locks
Ensure timely, high‑quality data delivery for decision points, regulatory filings, and publications
Lead vendor selection and oversight for EDC, IRT, ePRO, central labs, and other data‑generating systems
Establish and maintain SOPs, standards, and quality frameworks to ensure inspection readiness
Build and mentor a high‑performing CDM team
Qualification
Required
Bachelor's degree in life sciences, mathematics, public health, or related field
8+ years of clinical data management experience in biotech/pharma, with leadership responsibilities
Strong familiarity with FDA, EMA, and ICH‑GCP requirements
Excellent communication, leadership, and problem‑solving skills
Preferred
advanced degree preferred
Familiarity with data review, visualization, or reporting tools (e.g., SAS, R, or similar) is a plus
Experience in immunology, neurology, oncology or inflammation‑related clinical programs
Expertise with EDC platforms and CDM tools; experience with biomarker or lab‑intensive datasets is a plus
Benefits
Competitive compensation, equity, and comprehensive benefits.
Company
Halia Therapeutics, Inc.
Halia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases.
Funding
Current Stage
Growth StageTotal Funding
$47.56MKey Investors
Todd Pedersen
2025-07-16Series Unknown· $0.34M
2024-01-31Series C· $30M
2022-12-30Series Unknown· $12.22M
Leadership Team
Recent News
TechBuzz News
2025-12-02
Company data provided by crunchbase